AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

Renewed Hope for an HIV Vaccine

Dr. Carl Dieffenbach, PhD

In late September, the U.S. federal government announced news on HIV vaccine research that sparked interest around the world. A trial called RV144, or the Thai HIV vaccine clinical trial , showed that the experimental vaccine regimen was safe and about 31 percent effective in preventing HIV infection. Although the vaccine regimen had a very…

Dr. Anthony S. Fauci’s Statement for National Gay Men’s HIV/AIDS Awareness Day

Dr. Anthony Fauci

Last Sunday, September 27, Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Disease, National Institutes of Health, released a statement to acknowledge National Gay Men’s HIV/AIDS Awareness Day and research issues impacting gay men. To read the entire statement, visit the NIAID website. Anthony S. Fauci, M.D., Director of NIAID Gay…

HIV Vaccine Regimen Demonstrates Modest Preventive Effect in Thailand Clinical Study

blog.aids.gov

In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced…

HIV/AIDS Research Gets a Boost through ARRA

Dr. Carl Dieffenbach, PhD

Earlier this year, President Barack Obama signed the American Recovery and Reinvestment Act (ARRA) of 2009 into law to help stimulate the struggling U.S. economy. At the National Institute of Allergy and Infectious Disease (NIAID), part of the NIH, we have used ARRA funds to award high-quality, peer-reviewed grants focusing on research designed to help…

H1N1 Flu and HIV Webinar Highlights

H1N1 and HIV Webinar

Nearly 850 participants joined AIDS.gov online and/or via conference call last week to hear from leading experts and local grantees about H1N1 Preparedness and HIV. On the webinar we heard from our Federal colleagues, CDC’s Dr. John Brooks, and National Institute of Allergy and Infectious Diseases’ Dr. Elizabeth Higgs, along with Ryan White grantees such…

H1N1 Preparedness and HIV Webinar

National Institute of Allergy and Infectious Diseases Logo

Nearly 850 HIV federal colleagues staff and grantees participated in a webinar on Wednesday, September2, “H1N1 Preparedness & HIV” for the HIV community. Dr. Elizabeth Higgs, Deputy Branch Chief of the Collaborative Clinical Research Branch at the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health, spoke about their…

National HIV Prevention Conference Delivers Call to Action

2009 National HIV Prevention Conference. Promoting Synergy Between Science and Programs

I just returned from the National HIV Prevention Conference in Atlanta where a sense of excitement and renewed enthusiasm for fighting the HIV/AIDS pandemic were buoyed by the new opportunities that the Obama administration brings. Conversely, there was also an underlying current of anxiety about how our country’s economic situation is affecting HIV prevention services….

Testing HIV Drugs as Prevention

Dr. Carl Dieffenbach, PhD

Last year, the U.S. Centers for Disease Control and Prevention (CDC) announced that the number of annual new HIV infections in the United States is actually 40% higher than previously estimated. This means that more than 56,000 Americans are infected with HIV every year despite public education efforts on how to avoid getting infected. Addressing…